CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells

Majeti, Ravindra, Chao, Mark P., Alizadeh, Ash A., Pang, Wendy W., Jaiswal, Siddhartha, Gibbs, Kenneth D., van Rooijen, Nico, Weissman, Irving L.·2009·Cell

DOI 10.1016/j.cell.2009.05.045

Cited by (1,001)

Items 601–700 of 1,001

CD47: a potential immunotherapy target for eliminating cancer cells
Fanming Kong, Feng Gao, H. Li, Hongwei Liu, Y. Zhang, Rongxiu Zheng, Y. Zhang, J. Chen, Xuehua Li, G. Liu et al. · 2016 · Clinical & Translational Oncology
The Role of Tumor-Associated Macrophages in Leukemia
Yueyang Li, Mingjian James You, Ya‐Ling Yang, Dongzhi Hu, Chen Tian · 2019 · Acta Haematologica
Multiepitope supramolecular peptide nanofibers eliciting coordinated humoral and cellular antitumor immune responses
Yaoying Wu, Hanning Wen, Zachary J. Bernstein, Kelly M. Hainline, Tykia S. Blakney, Kendra L. Congdon, David J. Snyder, John Howard Sampson, Luis A Sanchez-Perez, Joel H. Collier · 2022 · Science Advances
Therapeutic modulation of APP-CD74 axis can activate phagocytosis of TAMs in GBM
Chengcheng Ma, Jiawen Chen, Jingsen Ji, Yaofeng Zheng, Yang Liu, Jihui Wang, Taoliang Chen, Huajian Chen, Zetao Chen, Quanwei Zhou et al. · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Unique dual targeting of thymidylate synthase and topoisomerase1 by FdUMP[10] results in high efficacy against AML and low toxicity
Timothy S. Pardee, Evan Gomes, Jamie E. Jennings‐Gee, David L. Caudell, William H. Gmeiner · 2012 · Blood
Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL
Kristina Müller, Fotini Vogiatzi, Dorothee Winterberg, Thies Rösner, Lennart Lenk, Lorenz Bastian, Carina Lynn Gehlert, Marie-Pauline Autenrieb, Monika Brüggemann, Gunnar Cario et al. · 2022 · Blood
VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells
Sandra Pinho, Qiao-Zhi Wei, Maria Maryanovich, Da-Chuan Zhang, J. Balandrán, Halley Pierce, Fumio Nakahara, Anna Di Staulo, Boris A. Bartholdy, Jianing Xu et al. · 2022 · Nature Cell Biology
Development and Characterization of Nanobody-Derived CD47 Theranostic Pairs in Solid Tumors
You Zhang, Di Zhang, Shuxian An, Qiufang Liu, Chenyi Liang, Juan Li, Ping Liu, Changfeng Wu, Gang Huang, Weijun Wei et al. · 2023 · Research
Targeting the CD47/SIRPα pathway in malignancies: recent progress, difficulties and future perspectives
Chenyang Jiang, Hao Sun, Zhongxing Jiang, Wenzhi Tian, Shundong Cang, Jifeng Yu · 2024 · Frontiers in Oncology
Signal Regulatory Protein α Is Associated With Tumor-Polarized Macrophages Phenotype Switch and Plays a Pivotal Role in Tumor Progression
Yufei Pan, Yexiong Tan, Min Wang, Jian Zhang, Bo Zhang, Chun Yang, Zhiwen Ding, Liwei Dong, Hongyang Wang · 2013 · Hepatology
CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL
Renée Bouwstra, Yuan Zhang He, Janneke de Boer, Hilde Kooistra, Ewa Cendrowicz, Rudolf S.N. Fehrmann, Emanuele Ammatuna, Christine zu Eulenburg, Marcel Nijland, Gerwin A. Huls et al. · 2019 · Cancer Immunology Research
Immunotherapeutic Blockade of CD47 Inhibitory Signaling Enhances Innate and Adaptive Immune Responses to Viral Infection
Lamin B. Cham, Laughing Bear Torrez Dulgeroff, Michal Caspi Tal, Tom Adomati, Fanghui Li, Hilal Bhat, Anfei Huang, Philipp Alexander Lang, Mary E. Moreno, Jose M. Rivera et al. · 2020 · Cell Reports
Cancer stem cells and macrophages: molecular connections and future perspectives against cancer
Beatrice Aramini, Valentina Masciale, Giulia Grisendi, Federico Banchelli, Roberto D’Amico, Antonino Maiorana, Uliano Morandi, Massimo Dominici, Khawaja Husnain Haider · 2021 · Oncotarget
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells.
Mia Eriksson, Pablo Peña-Martínez, Ramprasad Ramakrishnan, M. Chapellier, Carl Högberg, G. Glowacki, C. Orsmark-Pietras, Talia Velasco-Hernandez, V. Lazarevic, G. Juliusson et al. · 2017 · Blood Advances
Mapping and targeting of the leukemic microenvironment
Matthew T. Witkowski, Stavroula Kousteni, Iannis Aifantis · 2019 · The Journal of Experimental Medicine
The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer
Natasha Ustyanovska Avtenyuk, Nienke Visser, Edwin Bremer, Valerie R. Wiersma · 2020 · International Journal of Molecular Sciences
Regulation of CD47 expression by interferon-gamma in cancer cells
Zi-Han Ye, Xiaoming Jiang, Mu‐Yang Huang, Yulian Xu, Yu‐Chi Chen, Luo‐Wei Yuan, Can-Yu Huang, Wei‐Bang Yu, Xiuping Chen, Jin‐Jian Lu · 2021 · Translational Oncology
MICA/B antibody induces macrophage-mediated immunity against acute myeloid leukemia
Pedro Henrique Alves da Silva, Samantha Xing, Andriana G. Kotini, Eirini P. Papapetrou, Xiaoyu Song, Kai W. Wucherpfennig, John O Mascarenhas, Lucas Ferrari de Andrade · 2021 · Blood
Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia
Yoshikane Kikushige, Toshihiro Miyamoto · 2015 · Oncology
Emerging 2D Nanomaterials‐Integrated Hydrogels: Advancements in Designing Theragenerative Materials for Bone Regeneration and Disease Therapy
Melanie Zorrón, Agustín López Cabrera, Riya Sharma, Janani Radhakrishnan, Samin Abbaszadeh, Mohammad‐Ali Shahbazi, Omid Aghababaei Tafreshi, Solmaz Karamikamkar, Hajar Homa Maleki · 2024 · Advanced Science
Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer
Mario Orozco‐Morales, Giovanny Soca‐Chafre, Pedro Barrios‐Bernal, Norma Hernández‐Pedro, Oscar G. Arrieta · 2016 · Mediators of Inflammation
Bone marrow microenvironment: The guardian of leukemia stem cells
Mohammad Houshmand, Teresa Mortera Blanco, Paola Circosta, Narjes Yazdi, Alireza Kazemi, Giuseppe Nicola Saglio, Mahin Nikougoftar Zarif · 2019 · World Journal of Stem Cells
Interplay between dendritic cells and cancer cells
Jan Martínek, Te-Chia Wu, Diana Cadena, Jacques Banchereau, Karolina Palucka · 2019 · International review of cytology
Immune checkpoint inhibition in myeloid malignancies: Moving beyond the PD-1/PD-L1 and CTLA-4 pathways
Jan Philipp Bewersdorf, Rory Michael Shallis, Amer Methqal Zeidan · 2020 · Blood Reviews
CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia
Ramprasad Ramakrishnan, Pablo Peña-Martínez, Puneet Agarwal, Maria Rodriguez-Zabala, M. Chapellier, Carl Högberg, Mia Eriksson, David Yudovich, Mansi Shah, M. Ehinger et al. · 2020 · Cell Reports
Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma
Hao Wu, Jialin Liu, Zhifei Wang, Wen Yuan, Ling Chen · 2021 · CNS Neuroscience & Therapeutics
Acute myeloid leukemia targets for bispecific antibodies
Sayed Shahabuddin Hoseini, Nai‐Kong V. Cheung · 2017 · Blood Cancer Journal
Lamin A/C and the Immune System: One Intermediate Filament, Many Faces
Ángela Saéz, Beatriz Herrero‐Fernández, Raquel Gómez-Bris, Beatriz Somovilla-Crespo, Cristina Rius, José María González · 2020 · International Journal of Molecular Sciences
TNFSF15 facilitates differentiation and polarization of macrophages toward M1 phenotype to inhibit tumor growth
Can-Can Zhao, Qiu-Ju Han, Hao-Yan Ying, Xiang-Xiang Gu, Na Yang, Lu-Yuan Li, Qiang-Zhe Zhang · 2022 · OncoImmunology
Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy
Yun Yang, He Wu, Yan Yang, Yan Kang, Runjia He, Bei Zhou, Huaizu Guo, Jing Zhang, Jianqin Li, Chunpo Ge et al. · 2023 · Molecular Therapy — Oncolytics
Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosis
Sharika Bamezai, Yapei Zhang, Manisha Kumari, Mozhgan Lotfi, Tom Alsaigh, Lingfeng Luo, Gayatri Suresh Kumar, Fudi Wang, Jianqin Ye, Madhu Puri et al. · 2024 · Nature Communications
The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment
Chika Iwamoto, Katsuto Takenaka, Shingo Urata, Takuji Yamauchi, Takahiro Shima, Takuro Kuriyama, Shinya Daitoku, Yasuyuki Saito, Toshihiro Miyamoto, Hiromi Iwasaki et al. · 2013 · Experimental Hematology
CD47 is expressed abnormally on hematopoietic cells in myelodysplastic syndrome
Huijuan Jiang, Rong Fu, Huaquan Wang, Lijuan Li, Hui Liu, Zonghong Shao · 2013 · Leukemia Research
Divergent modulation of normal and neoplastic stem cells by thrombospondin-1 and CD47 signaling
Sukhbir Kaur, David D. Roberts · 2016 · The International Journal of Biochemistry & Cell Biology
Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles
Shoshy Mizrahy, Inbal Hazan‐Halevy, Dalit Landesman‐Milo, Brandon D. Ng, Dan Peer · 2017 · Frontiers in Immunology
CD97 is a critical regulator of acute myeloid leukemia stem cell function
G. Martin, Nainita Roy, Sohini Chakraborty, A. Desrichard, Stephen S. Chung, C. Woolthuis, Wen-Huo Hu, Iryna Berezniuk, F. Garrett-Bakelman, J. Hamann et al. · 2019 · Journal of Experimental Medicine
CRISPR screen in mechanism and target discovery for cancer immunotherapy
Dan Liu, Xuan Zhao, Anqun Tang, Xiyue Xu, Shuci Liu, Li Zha, Wen Ma, Junnian Zheng, Ming Shi · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
The promise and perils of immunotherapy
Stefanie Lesch, Saar I. Gill · 2021 · Blood Advances
Leveraging microenvironmental synthetic lethalities to treat cancer
Metcalf, Kevin J., Alazzeh, Alaa, Werb, Zena, Weaver, Valerie M. · 2021 · Journal of Clinical Investigation
Maintenance therapy in acute myeloid leukemia: advances and controversies
Jayastu Senapati, Tapan Mahendra Kadia, Farhad Ravandi · 2023 · Haematologica
Recent advances in functional bismuth chalcogenide nanomaterials: Cancer theranostics, antibacterial and biosensing
Qian Wang, Jun Du, Ruizhuo Ouyang, Baolin Liu, Yuqing Miao, Yuhao Li · 2023 · Coordination Chemistry Reviews
Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies
Wenyue Sun, Shunfeng Hu, Xin Wang · 2024 · 癌症：英文版
Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia
Jianbiao Zhou, Wee Joo Chng · 2017 · Stem Cell Investigation
SIRPα/CD47 axis controls the maintenance of transplant tolerance sustained by myeloid-derived suppressor cells
Sabrina Pengam, Justine Durand, Claire Usal, Vanessa Gauttier, Nahzli Dilek, Bernard Martinet, Véronique Daguin, Caroline Mary, Virginie Thépenier, Géraldine Teppaz et al. · 2019 · American Journal of Transplantation
PET/MRI Improves Management of Children with Cancer
Lucia Baratto, K. Elizabeth Hawk, Lisa J. States, Jing Qi, Sergios Gatidis, Louise Kiru, Heike Elisabeth Daldrup-Link · 2021 · Journal of Nuclear Medicine
Dendritic Cell-Based Immunotherapy for Myeloid Leukemias
Christian M. Schürch, Carsten Riether, Adrian F. Ochsenbein · 2013 · Frontiers in Immunology
Emerging Biomaterials Imaging Antitumor Immune Response
Xianbin Ma, Meng‐Jie Zhang, Jingting Wang, Tian Zhang, Peng Xue, Yuejun Kang, Zhi‐Jun Sun, Zhigang Xu · 2022 · Advanced Materials
CD47: Beyond an immune checkpoint in cancer treatment
Huiting Bian, Yiwen Shen, Yudong Zhou, Dale G. Nagle, Ying‐Yun Guan, Weidong Zhang, Xin Luan · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
A Review of Childhood Acute Myeloid Leukemia: Diagnosis and Novel Treatment
Pei‐Chin Lin, Serena Tseng, MU-EN LEE · 2023 · Pharmaceuticals
Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration of macrophages expressing immunosuppressive genes into tumor in esophageal squamous cell carcinoma
Hidekazu Oyoshi, Junyan Du, Shunsuke A. Sakai, Riu Yamashita, Masayuki Okumura, Atsushi Motegi, Hidehiro Hojo, Masaki Nakamura, Hidenari Hirata, Hironori Sunakawa et al. · 2023 · Science Advances
Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer
Min Li, Wei Ye, Ke-Wang Luo · 2024 · Pharmaceutics
Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors
Margarida Ferreira-Teixeira, B. Parada, Paulo Rodrigues‐Santos, Vera Alves, Jose Silva Ramalho, Francisco José Caramelo, Vitor Manuel Leitão de Sousa, Flávio Reis, Célia M. F. Gomes · 2015 · Oncotarget
Loss of Dnmt3b accelerates MLL-AF9 leukemia progression
Y. Zheng, H. Zhang, Y. Wang, X. Li, P. Lu, F. Dong, Y. Pang, S. Ma, H. Cheng, Hao Sha et al. · 2016 · Leukemia
Therapeutic Antibodies for Myeloid Neoplasms—Current Developments and Future Directions
Christian M. Schürch · 2018 · Frontiers in Oncology
Advances of Nanoparticles for Leukemia Treatment
Jie Shen, Zhiguo Lü, Jianze Wang, Tianlu Zhang, H. J. Yang, Yan Li, Guiying Liu, Xin Zhang · 2020 · ACS Biomaterials Science & Engineering
Recent Advances of Tumor Therapy Based on the CD47-SIRPα Axis
Yuchen Wang, Chenxuan Zhao, Yang Liu, Chao Wang, Haojie Jiang, Yiqiao Hu, Jinhui Wu · 2022 · Molecular Pharmaceutics
Targeting STAT3 signaling reduces immunosuppressive myeloid cells in head and neck squamous cell carcinoma
Lin‐Lin Bu, Guang‐Tao Yu, Wei‐Wei Deng, Liang Mao, Jianfeng Liu, Si‐Rui Ma, Tengfei Fan, Bradford Hall, Ashok B. Kulkarni, Wen‐Feng Zhang et al. · 2016 · OncoImmunology
B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia
Giovanni Galletti, Federico Caligaris‐Cappio, Maria Teresa Sabrina Bertilaccio · 2016 · Leukemia
CD47‐SIRP α Axis as a Biomarker and Therapeutic Target in Cancer: Current Perspectives and Future Challenges in Nonsmall Cell Lung Cancer
Rodrigo Catalán, Mario Orozco‐Morales, Norma Hernández‐Pedro, Alberto Güijosa, Ana Laura Colín-González, Federico Ávila‐Moreno, Oscar G. Arrieta · 2020 · Journal of Immunology Research
The Role of Ageing and Parenchymal Senescence on Macrophage Function and Fibrosis
Ross Campbell, Marie-Helena Docherty, David A. Ferenbach, Katie J. Mylonas · 2021 · Frontiers in Immunology
Modulation of CD47-SIRPα innate immune checkpoint axis with Fc-function detuned anti-CD47 therapeutic antibody
Rama Krishna Narla, Hardik Modi, Daniel Bauer, Mahan Abbasian, Jim C. Leisten, Joseph R. Piccotti, Stephan Kopytek, Brendan P. Eckelman, Quinn L. Deveraux, John C. Timmer et al. · 2021 · Cancer Immunology Immunotherapy
Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy
Lin Tian, Anhua Lei, Tianyu Tan, Mengmeng Zhu, Li Zhang, Haibo Mou, Jin Zhang · 2021 · Kidney Diseases
Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity
Siddhartha Sen, Duane C. Hassane, Cheryl A. Corbett, Michael W. Becker, Craig T. Jordan, Mónica L. Guzmán · 2013 · Experimental Hematology
Targeting the Innate Immune System as Immunotherapy for Acute Myeloid Leukemia
Emily K. Curran, Leticia P. Corrales, Justin Paul Kline · 2015 · Frontiers in Oncology
Targeting human CALR‐mutated MPN progenitors with a neoepitope‐directed monoclonal antibody
Denis Tvorogov, Chloe A. L. Thompson-Peach, Johannes Foßelteder, Mara Dottore, Frank C. Stomski, Suraiya A Onnesha, Kelly SY Lim, Paul A.B. Moretti, Stuart Maxwell Pitson, David M. Ross et al. · 2022 · EMBO Reports
Curcumin Reprograms TAMs from a Protumor Phenotype towards an Antitumor Phenotype via Inhibiting MAO-A/STAT6 Pathway
Mingjing Jiang, Ying Qi, Wei Huang, Ying Lin, Bo Li · 2022 · Cells
Interaction of tumor-associated microglia/macrophages and cancer stem cells in glioma
Xiangling Zhu, Yilong Fang, Yizhao Chen, Yu Chen, Wenming Hong, Wei Wei, Jiajie Tu · 2023 · Life Sciences
Multi-parameter fluorescence-activated cell sorting and analysis of stem and progenitor cells in myeloid malignancies
Britta Will, Ulrich G. Steidl · 2010 · Best Practice & Research Clinical Haematology
Role of autophagy in the maintenance and function of cancer stem cells
Ilio Vitale, Gwenola Manic, Vito Dandrea, Ruggero D. Maria · 2015 · The International Journal of Developmental Biology
Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with Kit Wv Mutations
Ayano Yurino, Katsuto Takenaka, Takuji Yamauchi, Takuya Nunomura, Yasufumi Uehara, Fumiaki Jinnouchi, Kohta Miyawaki, Yoshikane Kikushige, Koji Kato, Toshihiro Miyamoto et al. · 2016 · Stem Cell Reports
Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers
Md. Emranul Karim, Kyi Kyi Tha, Iekhsan Othman, Mohammad Borhan Uddin, Ezharul Hoque Chowdhury · 2018 · Pharmaceutics
Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition
Michal Caspi Tal, Laughing Bear Torrez Dulgeroff, Lara M. Myers, Lamin B. Cham, Katrin D. Mayer-Barber, Andrea C. Bohrer, Ehydel Castro, Ying Ying Yiu, Cesar J. Lopez Angel, Ed Pham et al. · 2020 · mBio
Emerging treatment options for patients with high-risk myelodysplastic syndrome
Jan Philipp Bewersdorf, Hetty E. Carraway, Thomas Prébet · 2020 · Therapeutic Advances in Hematology
Leukemic stem cells as a target for eliminating acute myeloid leukemia: Gaps in translational research
Sophia K. Khaldoyanidi, Antreas A. Hindoyan, Anthony Selwyn Stein, Marion Subklewe · 2022 · Critical Reviews in Oncology/Hematology
Inflammation as a driver of hematological malignancies
Sumedha Saluja, Ishu Bansal, Ruchi Bhardwaj, Mohammad Sabique Beg, Jayanth Kumar Palanichamy · 2024 · Frontiers in Oncology
Targeted delivery strategies: The interactions and applications of nanoparticles in liver diseases
Xiandi Meng, Ge Zhu, Yong‐Guang Yang, Tianmeng Sun · 2024 · Biomedicine & Pharmacotherapy
p16INK4A-expressing mesenchymal stromal cells restore the senescence–clearance–regeneration sequence that is impaired in chronic muscle inflammation
Takako Chikenji, Yuki Saito, Naoto Konari, Masako Nakano, Yuka Mizue, Miho Otani, Mineko Fujimiya · 2019 · EBioMedicine
Nanotherapeutic Shots through the Heart of Plaque
Yogendra M. Kanthi, Adam de la Zerda, Bryan Ronain Smith · 2020 · ACS Nano
Immunotherapy in Hodgkin and non-Hodgkin lymphoma: Innate, adaptive and targeted immunological strategies
Aung Myint Tun, Stephen Maxted Ansell · 2020 · Cancer Treatment Reviews
Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
Ji‐Yoon Noh, Huiyun Seo, Jungwoon Lee, Haiyoung Jung · 2020 · International Journal of Molecular Sciences
Engineered Multifunctional Nano‐ and Biological Materials for Cancer Immunotherapy
Anthony Brouillard, Nilesh Deshpande, Ashish A. Kulkarni · 2021 · Advanced Healthcare Materials
Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias
Julian Swatler, Laura Turos-Korgul, Ewa Kozłowska, Katarzyna Piwocka · 2021 · Cancers
Inhibition of phospholipase D1 induces immunogenic cell death and potentiates cancer immunotherapy in colorectal cancer
Won Chan Hwang, Doona Song, Hyesung Lee, Changmok Oh, Seong Hun Lim, Hyeon Jeong Bae, Nam Doo Kim, Gyoonhee Han, Do Sik Min · 2022 · Experimental & Molecular Medicine
A miRNA-based gene therapy nanodrug synergistically enhances pro-inflammatory antitumor immunity against melanoma
Yawen Ma, Huimin Lin, Peng Wang, Hao‐Cheng Yang, Jie Zhong Yu, Hao Tian, Tianyu Li, Shengfang Ge, Yilong Wang, Renbing Jia et al. · 2022 · Acta Biomaterialia
Erratum: Acute myeloid leukemia targets for bispecific antibodies
Sayed Shahabuddin Hoseini, Nai‐Kong V. Cheung · 2017 · Blood Cancer Journal
Stealth missiles with precision guidance: A novel multifunctional nano-drug delivery system based on biomimetic cell membrane coating technology
Yuyan Zhou, Xinyue Wang, Xiaorong Tian, Deyu Zhang, Hanxiao Cui, Wei Du, Zhenghui Yang, Jia-yu Li, Wanshun Li, Jiaheng Xu et al. · 2025 · Materials Today Bio
Cancer stem cell subsets and their relationships
Haiguang Liu, Chong Chen, Han Yang, Yifei Pan, Xiaohua Zhang · 2011 · Journal of Translational Medicine
Anti-CD47 antibodies induce phagocytosis of live, malignant B cells by macrophages via the Fc domain, resulting in cell death by phagoptosis
Lucy E. Métayer, Anna Vilalta, G.A. Amos Burke, Guy Charles Brown · 2017 · Oncotarget
Therapeutic targeting of leukemic stem cells in acute myeloid leukemia – the biological background for possible strategies
Øystein Bruserud, Elise Aasebø, Maria Hernandez-Valladares, Galina Tsykunova, Håkon Reikvam · 2017 · Expert Opinion on Drug Discovery
Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC (Review)
Lige Qiu, Hailiang Li, Sirui Fu, Xiaofang Chen, Ligong Lu · 2017 · Oncology Letters
Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response
Aditya Barve, Lavona K. Casson, Maxwell M. Krem, Mark Wunderlich, James C. Mulloy, Levi J. Beverly · 2018 · Experimental Hematology
Tumor cellular membrane camouflaged liposomes as a non-invasive vehicle for genes: specific targeting toward homologous gliomas and traversing the blood–brain barrier
Ying‐Zheng Zhao, Bi‐Xin Shen, Xin-Ze Li, Meng‐Qi Tong, Pengpeng Xue, Rui Chen, Qing Yao, Bin Chen, Jian Xiao, Helin Xu · 2020 · Nanoscale
Leukemia Stem Cell Release From the Stem Cell Niche to Treat Acute Myeloid Leukemia
Alicia Villatoro, Joanna Konieczny, Vincent Cuminetti, Lorena Arranz · 2020 · Frontiers in Cell and Developmental Biology
Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha
Karen De Vlaminck, Ema Romão, Janik Puttemans, Ana Rita Pombo Antunes, Daliya Kancheva, Isabelle Scheyltjens, Jo A. Van Ginderachter, Serge Muyldermans, Nick Devoogdt, Kiavash Movahedi et al. · 2021 · Frontiers in Immunology
The Role of Inflammation in Leukaemia
Janusz Krawczyk, Michael E O'Dwyer, Ronan T. Swords, Ciara Louise L. Freeman, Francis Joseph Giles · 2014 · Advances in experimental medicine and biology
A pH-dependent anti-CD47 antibody that selectively targets solid tumors and improves therapeutic efficacy and safety
Yulu Li, Juan Liu, Wei Chen, Wei Wang, Fang Yang, Ximing Liu, Sheng Yao, Kaixin Du, Miaomiao He, Xueyuan Lyu et al. · 2023 · Journal of Hematology & Oncology
Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial
Amitkumar Mehta, Leslie L. Popplewell, Graham P. Collins, Sonali M. Smith, Ian W. Flinn, Nancy L. Bartlett, Nilanjan Ghosh, Gal Hacohen-Kleiman, Yanan Huo, Linda Su-Feher et al. · 2024 · Blood Advances
Advancements in conventional cancer therapy combined with immunotherapy
Hongxia Li, Songyan Han, Chunbo Dong, Zhida Liu · 2024 · Oncology and Translational Medicine
Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo
Анна Сергеева, Hong He, Kathryn E. Ruisaard, Lisa S. St. John, Gheath Alatrash, Karen Clise-Dwyer, D. Li, Rebecca S Patenia, R Hong, Pariya Sukhumalchandra et al. · 2016 · Leukemia
Checkpoint inhibition in pediatric hematologic malignancies
Kara Lynn Davis, Archana M. Agarwal, Anupam R. Verma · 2017 · Pediatric Hematology and Oncology